HCSGD entry for FAS
1. General information
Official gene symbol | FAS |
---|---|
Entrez ID | 355 |
Gene full name | Fas cell surface death receptor |
Other gene symbols | ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0002377 | Immunoglobulin production | IEA | biological_process |
GO:0003014 | Renal system process | IEA | biological_process |
GO:0004871 | Signal transducer activity | TAS | molecular_function |
GO:0004872 | Receptor activity | NAS | molecular_function |
GO:0004888 | Transmembrane signaling receptor activity | IEA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005576 | Extracellular region | IEA | cellular_component |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0005829 | Cytosol | NAS | cellular_component |
GO:0005886 | Plasma membrane | IDA IMP TAS | cellular_component |
GO:0006461 | Protein complex assembly | TAS | biological_process |
GO:0006915 | Apoptotic process | IDA IEA TAS | biological_process |
GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | TAS | biological_process |
GO:0006924 | Activation-induced cell death of T cells | IEA | biological_process |
GO:0006925 | Inflammatory cell apoptotic process | IEA | biological_process |
GO:0006927 | Transformed cell apoptotic process | IEA | biological_process |
GO:0006955 | Immune response | IEA | biological_process |
GO:0007165 | Signal transduction | TAS | biological_process |
GO:0008625 | Extrinsic apoptotic signaling pathway via death domain receptors | IEA | biological_process |
GO:0009636 | Response to toxic substance | IEA | biological_process |
GO:0009897 | External side of plasma membrane | IEA | cellular_component |
GO:0009986 | Cell surface | IDA | cellular_component |
GO:0010467 | Gene expression | IEA | biological_process |
GO:0010940 | Positive regulation of necrotic cell death | IMP | biological_process |
GO:0016020 | Membrane | IEA | cellular_component |
GO:0016021 | Integral component of membrane | IEA | cellular_component |
GO:0019724 | B cell mediated immunity | IEA | biological_process |
GO:0019900 | Kinase binding | IPI | molecular_function |
GO:0031264 | Death-inducing signaling complex | IDA | cellular_component |
GO:0031265 | CD95 death-inducing signaling complex | IDA | cellular_component |
GO:0032464 | Positive regulation of protein homooligomerization | IEA | biological_process |
GO:0042802 | Identical protein binding | IPI | molecular_function |
GO:0042981 | Regulation of apoptotic process | NAS | biological_process |
GO:0043065 | Positive regulation of apoptotic process | IDA IMP | biological_process |
GO:0043066 | Negative regulation of apoptotic process | IEA | biological_process |
GO:0045060 | Negative thymic T cell selection | IEA | biological_process |
GO:0045121 | Membrane raft | IDA | cellular_component |
GO:0045619 | Regulation of lymphocyte differentiation | IEA | biological_process |
GO:0045637 | Regulation of myeloid cell differentiation | IEA | biological_process |
GO:0048536 | Spleen development | IEA | biological_process |
GO:0050869 | Negative regulation of B cell activation | IEA | biological_process |
GO:0051260 | Protein homooligomerization | IEA | biological_process |
GO:0051384 | Response to glucocorticoid | IEA | biological_process |
GO:0071260 | Cellular response to mechanical stimulus | IEP | biological_process |
GO:0071285 | Cellular response to lithium ion | IEA | biological_process |
GO:0071455 | Cellular response to hyperoxia | IMP | biological_process |
GO:0097049 | Motor neuron apoptotic process | IEA | biological_process |
GO:0097190 | Apoptotic signaling pathway | TAS | biological_process |
GO:0097191 | Extrinsic apoptotic signaling pathway | IMP | biological_process |
GO:0097192 | Extrinsic apoptotic signaling pathway in absence of ligand | IEA | biological_process |
GO:2001239 | Regulation of extrinsic apoptotic signaling pathway in absence of ligand | TAS | biological_process |
GO:2001241 | Positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0149432734 | 0.6608386991 | 0.3039581917 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.4308773583 |
GSE13712_SHEAR | Up | 1.5372149368 |
GSE13712_STATIC | Up | 1.5639236550 |
GSE19018 | Up | 0.0747281279 |
GSE19899_A1 | Down | -0.2723098051 |
GSE19899_A2 | Down | -0.1596793079 |
PubMed_21979375_A1 | Up | 0.2154736373 |
PubMed_21979375_A2 | Up | 0.7551270665 |
GSE35957 | Down | -0.1215075076 |
GSE36640 | Up | 1.4614163744 |
GSE54402 | Down | -1.2346394635 |
GSE9593 | Up | 0.4294630271 |
GSE43922 | Up | 0.2384902775 |
GSE24585 | Down | -0.0162241783 |
GSE37065 | Up | 0.5722434981 |
GSE28863_A1 | Up | 0.1660923422 |
GSE28863_A2 | Down | -0.0907173187 |
GSE28863_A3 | Down | -0.5533708869 |
GSE28863_A4 | Up | 0.2458785367 |
GSE48662 | Down | -0.0790977177 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-106a-5p | MIMAT0000103 | MIRT006331 | Luciferase reporter assay | Functional MTI | 22431000 |
hsa-miR-21-5p | MIMAT0000076 | MIRT002421 | Microarray | Functional MTI (Weak) | 20048743 |
hsa-miR-146a-5p | MIMAT0000449 | MIRT005581 | Luciferase reporter assay//Western blot | Functional MTI | 20656888 |
hsa-miR-504-5p | MIMAT0002875 | MIRT016252 | qRT-PCR | Functional MTI (Weak) | 20542001 |
hsa-miR-98-5p | MIMAT0000096 | MIRT027598 | Microarray | Functional MTI (Weak) | 19088304 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 6 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
25392765 | The CD8 T cell phenotype was defined by the surface expression of CD28 and CD95 |
22613541 | The frequency of CD28 and CD95 demonstrated a "curved" rather than linear tendency by age |
20137575 | Altered CD28 and CD95 mRNA expression in peripheral blood mononuclear cells from elderly patients with primary non-small cell lung cancer |
20137575 | BACKGROUND: The expression of the co-stimulatory molecule CD28 and death receptor CD95 on T cells, which change with age, are considered as important immunological parameters of immunosenescence |
20137575 | It is well established that CD28 and CD95 are associated with tumorgenesis and tumor progression, but the relationship between the age-related changes of these two immunological markers and cancer in the elderly is largely unknown |
20137575 | METHODS: The levels of CD28 and CD95 mRNA in peripheral blood mononuclear cells (PBMCs) from sixty-three elderly patients (aged > or = 60 years) with primary non-small cell lung cancer (NSCLC) were analyzed by real-time fluorescence-based quantitative polymerase chain reaction (FQ-PCR) |
20137575 | RESULTS: CD28 mRNA levels were significantly lower and CD95 mRNA levels were significantly higher in elderly patients with NSCLC than in the other groups |
20137575 | By Logistic regression analysis an increased risk of NSCLC was markedly associated with aging, down-regulation of CD28 mRNA and up-regulation of CD95 mRNA, and CD28 mRNA had an obvious negative correlation with the CD95 mRNA |
20137575 | In addition, the mRNA levels of CD28 and CD95 in the peripheral blood of the elderly patients was closely associated with the tumor node metastasis (TNM) stages, grade of cell differentiation and lymph node metastasis status, but not related to pathological types |
20137575 | CONCLUSIONS: The results suggest a close relationship between T cell senescence and NSCLC tumour progress in the elderly, and that up-regulation of CD28 mRNA or down-regulation of CD95 mRNA in peripheral blood T cells may play an important role in inhibiting oncogenesis and development of primary NSCLC in the elderly |
16951143 | In this study, we used chromatin immunoprecipitation to determine that p53 preferentially occupied the promoters of growth arrest genes p21 and GADD45 in senescent normal human diploid fibroblasts but not the promoters of other target genes that recruited p53 following doxorubicin-induced DNA damage, such as apoptosis regulators TNFRSF10b, TNFRSF6, and PUMA |
15130673 | Cell death following stimulations: (i) corresponded to apoptosis, associated with necrosis at the end of the culture; (ii) was not, for its main part, mediated through CD95/CD178 or TNFRII/TNF alpha interactions; and (iii) occurred in spite of bcl-2 increased expression |
8688670 | Regulation of CD95 (APO-1) expression and the induction of apoptosis in human T cells: changes in old age |
8688670 | CD95 (APO-1) is a member of the TNF/nerve growth factor receptor superfamily, which is expressed on the surface of different types of cells |
8688670 | Cross-linking of CD95 leads to the induction of apoptosis |
8688670 | In view of the known decline of immune function in old age it seemed of interest to study the expression and inducibility of CD95 in peripheral blood T lymphocytes from young and old healthy subjects selected according to the guidelines laid down in the Senieur protocol of the European Community's Concerted Action Programme on Aging |
8688670 | Resting T cells did not express CD95 |
8688670 | The activation-induced increase in CD95 expression was followed by a decrease, which was observed in both age groups, but was less pronounced in old subjects |
8688670 | Under long-term culture conditions T cell lines derived from both young and old individuals progressively lost the capacity to decrease the expression of CD95 at the end of their activation cycle and an increasing susceptibility to activation-driven programmed cell death was noted |
8688670 | The results suggest that a lowered sensitivity in the regulation of CD95 as well as an increased susceptibility to apoptosis-inducing mechanisms during clonal expansion are features of T cell senescence |
Entries Per Page
Displaying Page of